𝛼SK or Search

ENTITY

Luye Pharma Group (2186 HK)

134

Analysis

Health Care • China

Luye Pharma Group is an international pharmaceutical company dedicated to the research, development, manufacturing, and sale of innovative medications. The company focuses on four main therapeutic areas: oncology, central nervous system, cardiovascular, and gastrointestinal/metabolic disorders, utilizing advanced drug delivery systems. It was founded in 1994 and is headquartered in Shanghai, China.

more

Refresh

Exchange Announcement • 29 Sep 2026 22:00

Interim Report 2026

Exchange Announcement • 30 Aug 2026 19:30

Announcement Of Interim Results For The Six Months Ended 30 June 2026

Exchange Announcement • 20 Aug 2026 22:30

Voluntary Announcement Mrna Vaccine Ly01620 For The Treatment Of Cervical Precancerous Lesions And Hpv-Related Tumors To Enter Into Phase Ii Clinical Trial In China

Exchange Announcement • 17 Aug 2026 22:00

Notice Of Board Meeting

Exchange Announcement • 05 Aug 2026 21:00

Voluntary Announcement Successful Completion Of A U.S. Bridging Clinical Trial Of The Group'S Innovative Drug Ly03015 (Vmat2 Inhibitor/Sigma-1r Agonist)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x